Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2014; 20(40): 14841-14854
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14841
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14841
Figure 6 Release of interleukin 6 (A), hypoxia-inducible factor 1 alpha (B) and transforming growth factor beta 1 (C) in the serum after liver resection in three different groups at 1, 3 and 24 h.
Values are given as mean ± SE. 2-way ANOVA. Bonferroni’s post-test: aP < 0.05 vs CG; dP < 0.01 vs BDL + M; fP < 0.01 vs BDL (n = 15). CG: Control group; BDL: Bile duct ligation; BDL + M: BDL + meloxicam; IL-6: Interleukin 6; HIF-1α: Hypoxia-inducible factor 1 alpha; TGF-β1: Transforming growth factor beta 1.
- Citation: Hamza AR, Krasniqi AS, Srinivasan PK, Afify M, Bleilevens C, Klinge U, Tolba RH. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. World J Gastroenterol 2014; 20(40): 14841-14854
- URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14841.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14841